Valuation: Amgen Inc.

Market Cap 23TCr 1,12600Cr 20TCr 19TCr 17TCr 32TCr 21,58000Cr 32TCr 2,26400Cr 89TCr 11,13600Cr 85TCr 83TCr 35,83600Cr P/E 2026 *
26.5x
P/E 2027 * 23.6x
Enterprise Value 27TCr 1,33300Cr 24TCr 22TCr 20TCr 38TCr 25,55200Cr 38TCr 2,68100Cr 1,04900Cr 13,18600Cr 1,00400Cr 98TCr 42,43200Cr EV / Sales 2026 *
6.86x
EV / Sales 2027 * 6.48x
Free-Float
99.77%
Yield 2026 *
2.42%
Yield 2027 * 2.55%
1 day-0.71%
1 week+3.15%
Current month-5.06%
1 month+7.33%
3 months+12.22%
6 months+18.23%
Current year+12.60%
1 week 71.54
Extreme 71.54
74.8
1 month 68.98
Extreme 68.98
80.47
Current year 48.4
Extreme 48.4
83.38
1 year 48.4
Extreme 48.4
83.38
3 years 45.12
Extreme 45.12
83.38
5 years 37.52
Extreme 37.52
83.38
10 years 15.78
Extreme 15.780356
83.38
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Chief Tech/Sci/R&D Officer 57 01/06/2023
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%+3.15% - - 22TCr
+0.28%+3.46%+41.89%+93.71% 1,05100Cr
+0.88%+4.27%+38.28%+68.70% 63TCr
+1.68%+5.78%+21.96%+89.56% 49TCr
-0.10%+4.24%+69.15%+40.41% 36TCr
+0.61%+3.18%+24.05%+42.46% 34TCr
+0.72%+2.99%+14.29%+34.71% 27TCr
+0.23%+2.23%-5.91%+8.15% 25TCr
+0.65%+3.62%+43.93%+46.50% 22TCr
-0.49%+4.01%+28.38%+95.97% 19TCr
Average +0.32%+3.11%+30.67%+57.80% 42.26TCr
Weighted average by Cap. +0.35%+3.18%+34.07%+66.93%

Financials

2026 *2027 *
Net sales 3.9TCr 19TCr 3.49TCr 3.25TCr 2.95TCr 5.56TCr 3,72500Cr 5.6TCr 39TCr 15TCr 1,92200Cr 15TCr 14TCr 6,18600Cr 4.04TCr 20TCr 3.61TCr 3.37TCr 3.06TCr 5.76TCr 3,85900Cr 5.8TCr 40TCr 16TCr 1,99100Cr 15TCr 15TCr 6,40900Cr
Net income 853.1Cr 4.25TCr 763.7Cr 711.93Cr 645.74Cr 1.22TCr 82TCr 1.23TCr 8.56TCr 3.35TCr 42TCr 3.2TCr 3.13TCr 1,35400Cr 939Cr 4.68TCr 840.59Cr 783.61Cr 710.76Cr 1.34TCr 90TCr 1.35TCr 9.42TCr 3.69TCr 46TCr 3.53TCr 3.45TCr 1,49100Cr
Net Debt 4.16TCr 21TCr 3.72TCr 3.47TCr 3.15TCr 5.93TCr 3,97200Cr 5.97TCr 42TCr 16TCr 2,05000Cr 16TCr 15TCr 6,59600Cr 3.59TCr 18TCr 3.21TCr 3TCr 2.72TCr 5.12TCr 3,43200Cr 5.16TCr 36TCr 14TCr 1,77100Cr 13TCr 13TCr 5,69800Cr
Projected Income Statement - Annual - Amgen Inc.
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
09/26/09 R$74.27 -0.71% 74
08/26/08 R$74.80 +0.92% 1,089
07/26/07 R$74.12 +3.30% 63
06/26/06 R$71.75 -0.35% 200
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Amgen Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
417.57USD
Average target price
393.91USD
Spread / Average Target
-5.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Amgen Inc.